Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;33(6):1085-9.
doi: 10.1007/s11064-007-9554-z. Epub 2007 Dec 20.

Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice

Affiliations

Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice

Rui-Sheng Duan et al. Neurochem Res. 2008 Jun.

Abstract

Chemokines and their receptors have been strongly implicated in the inflammatory process and pathogenesis of the neurodegenerative disorders, such as Alzheimer's disease (AD). In the present study, we examined the expression of chemokines, fractalkine, interferon-inducible protein-10 (IP-10) and macrophage inflammatory protein-1alpha (MIP-1alpha) by immunohistochemistry in the brain of transgenic mice APP SWE (Tg2576) at ages of 9, 11, and 17 months, which over-express a mutated form of human amyloid precursor protein (APP). Decreased fractalkine and increased IP-10 expression in cerebral cortex and hippocampus were found at ages of 9 and 17 months in Tg2576 mice when compared with age-matched control mice. On the contrary, MIP-1alpha expression showed no difference between Tg2576 mice and aged controls and was not influenced by ages. beta-amyloid (Abeta) positive plaques were co-located with the intense IP-10 expression. The finding suggests fractalkine and IP-10 may participate in the pathogenesis of AD; and could be new therapeutic strategies for neuroprotection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Neurobiol Aging. 2000 May-Jun;21(3):383-421 - PubMed
    1. Am J Pathol. 1998 Jan;152(1):307-17 - PubMed
    1. J Neuroimmunol. 2002 Jun;127(1-2):160-8 - PubMed
    1. J Neuroimmunol. 2000 Aug 1;108(1-2):227-35 - PubMed
    1. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10896-901 - PubMed

Publication types